Vaccines, Antibodies and Drug Libraries. The Possible COVID-19 Treatments Researchers Are Excited About
In early April, about four months after a new, highly infectious coronavirus was first identified in China, an international group of scientists reported encouraging results from a study of an experimental drug for treating the viral disease known as COVID-19. It was a small study, reported in the New England Journal of Medicine, but showed that remdesivir, an unapproved drug that was originally developed to fight Ebola, helped 68% of patients with severe breathing problems due to COVID-19 to improve; 60% of those who relied on a ventilator to breathe and took the drug were able to wean themselves off the machines after 18...
Source: TIME: Health - April 14, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

All Your Coronavirus Questions, Answered
One of the worst symptoms of any plague is uncertainty—who it will strike, when it will end, why it began. Merely understanding a pandemic does not stop it, but an informed public can help curb its impact and slow its spread. It can also provide a certain ease of mind in a decidedly uneasy time. Here are some of the most frequently asked questions about the COVID-19 pandemic from TIME’s readers, along with the best and most current answers science can provide. A note about our sourcing: While there are many, many studies underway investigating COVID-19 and SARS-CoV-19, the novel coronavirus that causes the illn...
Source: TIME: Health - April 14, 2020 Category: Consumer Health News Authors: TIME Staff Tags: Uncategorized COVID-19 Explainer Source Type: news

Trump’s malaria drug hope: ‘game changer’ or dangerous gamble?
What the research shows about using hydroxychloroquine for Covid-19 (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 14, 2020 Category: Pharmaceuticals Source Type: news

Heart woes spur partial stop of malaria drug study for virus
Scientists in Brazil have stopped part of a study of a malaria drug touted as a possible coronavirus treatment after heart rhythm problems developed in one-quarter of people given the higher of two doses being tested (Source: ABC News: Health)
Source: ABC News: Health - April 13, 2020 Category: Consumer Health News Tags: Health Source Type: news

Africa: COVID-19 Will Make Malaria Tracing and Treatment Much Harder - WHO
[RFI] Covid-19 could complicate tracing and treatment of malaria and compromise wider public health programmes, new guidance from the World Health Organisation says, as Zimbabwe reported its own significant spike in the mosquito-borne disease. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 13, 2020 Category: Infectious Diseases Source Type: news

Debunking 9 Popular Myths Doing the Rounds in Africa About the Coronavirus
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post Debunking 9 Popular Myths Doing the Rounds in Africa About the Coronavirus appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - April 13, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Africa Headlines Health TerraViva United Nations Coronavirus Source Type: news

Deadliest malaria strain protects itself from the immune system
(The Francis Crick Institute) The parasite causing the most severe form of human malaria uses proteins to make red blood cells sticky, making it harder for the immune system to destroy it and leading to potentially fatal blood clots. New research at the Crick has identified how the parasite may control this process. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 13, 2020 Category: International Medicine & Public Health Source Type: news

Don't worry, HCQ info's a click away
The move will likely ease the worries of thousands of Indians who have been prescribed the drug for certain ailments — including malaria and autoimmune disorders like rheumatoid arthritis and lupus — but are facing difficulty in getting it after India lifted a ban on its export last week. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 13, 2020 Category: Pharmaceuticals Source Type: news

President Trump is wrong in so many ways about hydroxychloroquine studies. Here are the facts
There are several treatments being studied to prevent or treat coronavirus, but President Trump has been a cheerleader for one in particular: hydroxychloroquine, a drug currently used to treat malaria, lupus and rheumatoid arthritis. (Source: CNN.com - Health)
Source: CNN.com - Health - April 11, 2020 Category: Consumer Health News Source Type: news

Pharmaceutical firm to donate two million tablets of malaria drug to world's largest COVID-19 trial 
Accord Healthcare Ltd, a global medicine distributor, will supply hydroxychloroquine to 40,000 frontline doctors in the COPCOV study led by University of Oxford. (Source: the Mail online | Health)
Source: the Mail online | Health - April 10, 2020 Category: Consumer Health News Source Type: news

Zimbabwe: Malaria Kills 6 in Beitbridge, Gwanda
[The Herald] Matabeleland South Province has this year recorded an increase in malaria cases with six deaths reported in Gwanda and Beitbridge districts. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 10, 2020 Category: Infectious Diseases Source Type: news

Sanofi will donate 100 million doses of hydroxychloroquine to 50 countries
French pharmaceutical giant Sanofi said Friday it had decided to donate 100 million doses of hydroxychloroquine, the decades-old anti-malaria drug touted by some as a potential weapon against the novel coronavirus, across 50 countries. (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

After Donald Trump's Hydroxychloroquine clamour Bengal planters hope for surge in quinine demand
US President Donald Trump's strong advocacy of Hydroxychloroquine for treating COVID-19 patients has rekindled hopes of cinchona planters of Darjeeling hills as the tree's bark is used for production of quinine, another frontline anti-malaria medicine. (Source: The Economic Times)
Source: The Economic Times - April 10, 2020 Category: Consumer Health News Source Type: news

NIH begins trial to test hydroxychloroquine for treating COVID-19
The National Institutes of Health (NIH) said on Thursday it was testing anti-malaria drug hydroxychloroquine for treating COVID-19, days after several U.S. doctors said they were using the drug on infected patients without evidence that it worked. (Source: Reuters: Health)
Source: Reuters: Health - April 9, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Botswana: Malaria Cases Increase in Bobirwa
[Botswana Daily News] Bobonong -The acting chief medical officer at Bobonong Primary Hospital, Dr Jean Lundemba, is has decried the increasing cases of malaria in Bobirwa region. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 9, 2020 Category: Infectious Diseases Source Type: news

Namibia: Over 800 Malaria Cases in Kavango
[New Era] The ministry of health in Kavango West and Kavango East region have reported about 827 malaria cases, while inhabitants are being encouraged to use mosquito repellents to curb the spread. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 9, 2020 Category: Infectious Diseases Source Type: news

Tailoring Malaria Interventions in the COVID-19 Response
Source: World Health Organization (WHO). Published: 4/9/2020. This 34-page document provides overarching principles, as well as specific technical guidance, for malaria interventions, including prevention of infection and disease, care and treatment of cases, testing, clinical services, supply chain, and laboratory activities, during this time of the evolving COVID-19 pandemic. (PDF) (Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - April 9, 2020 Category: International Medicine & Public Health Source Type: news

Hydroxychloroquine and Coronavirus: Fact-Check on the Malaria Drug Trump Keeps Pushing
Here are the facts on hydroxychloroquine, which the president has promoted despite little evidence that it works against the coronavirus. (Source: NYT)
Source: NYT - April 9, 2020 Category: American Health Authors: Denise Grady, Katie Thomas and Patrick J. Lyons Tags: Hydroxychloroquine (Drug) Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Stockpiling Autoimmune Diseases Research Malaria Clinical Trials your-feed-healthcare Source Type: news

CDC pulls confusing dosing guidance for malaria drug that Trump praised for treating coronavirus
The CDC's website originally referenced anecdotal reports that the drugs may help treat coronavirus patients. Now the website states no drugs are approved to prevent or treat the virus. (Source: the Mail online | Health)
Source: the Mail online | Health - April 9, 2020 Category: Consumer Health News Source Type: news

New infographic: How we are fighting COVID-19
America ’s biopharmaceutical companies have joined forces to fight COVID-19. Armed with experience garnered from previous outbreaks and a vast storehouse of knowledge about infectious diseases like influenza, malaria and HIV, researchers are working to develop and deliver diagnostics, treatments and vacci nes to save lives and restore the rhythms of daily life for billions of people. (Source: The Catalyst)
Source: The Catalyst - April 8, 2020 Category: Pharmaceuticals Authors: Tom Wilbur Tags: Coronavirus Source Type: news

Want to Stop the Next Pandemic? Start Protecting Wildlife Habitats
(Bloomberg) — There are four critical facets of pandemic prevention, according to Lee Hannah, senior scientist at Conservation International. Three of them make immediate sense against the backdrop of our current emergency: stockpile masks and respirators; have testing infrastructure ready; and ban the global wildlife trade, including the open animal markets where COVID-19 may have first infected people. His fourth recommendation is more grandiose: “Take care of nature.” The assault on ecosystems that allowed COVID-19 to jump from animals to humans went far beyond merchants hunting and selling rare wildli...
Source: TIME: Science - April 8, 2020 Category: Science Authors: Eric Roston / Bloomberg Tags: Uncategorized COVID-19 News Desk wire Source Type: news

St. Jude experimental anti-malarial drug shows promise in first clinical trial
(St. Jude Children's Research Hospital) Malaria is a leading killer of children worldwide, and new drugs are needed. New research reports encouraging early clinical results with a new compound. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - April 8, 2020 Category: Infectious Diseases Source Type: news

Pressed by Trump, US Pushed Unproven Coronavirus Treatment Guidance Pressed by Trump, US Pushed Unproven Coronavirus Treatment Guidance
In mid-March, President Donald Trump personally pressed federal health officials to make malaria drugs available to treat the novel coronavirus, though they had been untested for COVID-19, two sources told Reuters.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 7, 2020 Category: Intensive Care Tags: Infectious Diseases News Source Type: news

After Trump ’s Retaliation Threat, India Lifts Restrictions On Hydroxychloroquine
Trump has touted the anti-malaria drug as a “game-changer” despite a lack of proof that it can cure coronavirus. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 7, 2020 Category: Pharmaceuticals Authors: Isabel Togoh, Forbes Staff Source Type: news

Few Doctors, Fewer Ventilators: African Countries Fear They Are Defenseless Against Inevitable Spread of Coronavirus
Zororo Makamba wasn’t supposed to die of the novel coronavirus. Not just because of his age, which at 30 placed him well out of the at-risk category for COVID-19 complications, but because of who he was. A well-known, pro-government media personality in Zimbabwe, and the son of a prominent business mogul, Makamba had the wealth and the connections that should have guaranteed him the best care possible. Instead, on March 23, Zimbabwe’s first confirmed case of the coronavirus died alone in a quarantined hospital, three days after his diagnosis. Hospital staff, lacking protective equipment, were afraid to come nea...
Source: TIME: Health - April 7, 2020 Category: Consumer Health News Authors: Aryn Baker / Cape Town Tags: Uncategorized COVID-19 Source Type: news

Rwanda ’s Nurses Communicate to Protect Themselves and Their Clients
By Casey Bishopp, Communications officer, IntraHealth International ; Philippe Kayibana, Community health facilitator, IngobyiApril 07, 2020Philippe Kayibanda is a registered nurse with 13 years of experience working to improve Rwanda’s health system. For him, it’s the power of communication that helps nurses meet their own needs while responding to COVID-19 and caring for patients.“I want nurses around the world to improve communication on their teams,” he says.“In order to be successful, we have to communicate our challenges, our experiences, and our lessons.”When Kayibanda became ...
Source: IntraHealth International - April 7, 2020 Category: International Medicine & Public Health Authors: cbishopp Tags: Infectious Diseases COVID-19 Education & Performance Leadership and Governance Health Workers Nurses Source Type: news

India releases hydroxychloroquine stocks amid pressure from Trump
US president called Modi and threatened ‘retaliation’ if country kept full export banCoronavirus – latest updatesSee all our coronavirus coverageIndia has approved some exports ofhydroxychloroquine, an anti-malaria drug being touted as a possible coronavirus treatment, after apparent pressure from Donald Trump, who has been urging Americans to take it.The tablets are used to prevent and treat malaria, lupus and rheumatoid arthritis but over the past week the US president has been aggressively promoting the drug as a treatment for coronavirus, despite there being no conclusive medical evidence to prove its...
Source: Guardian Unlimited Science - April 7, 2020 Category: Science Authors: Hannah Ellis-Petersen South Asia correspondent Tags: India South and Central Asia World news US news Malaria Coronavirus outbreak Infectious diseases Medical research Science Source Type: news

India allows limited exports of anti-malaria drug after Trump warns of retaliation
India, the world's main supplier of generic drugs, said on Tuesday it will allow limited exports of the anti-malaria drug hydroxychloroquine that U.S. President Donald Trump has touted as a potential weapon in the fight against the coronavirus. (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

India Partially Lifts Export Ban on Potential Coronavirus Treatment After Trump Call
India partially lifted a ban on the exports of a malaria drug after President Donald Trump sought supplies for the U.S., according to government officials with knowledge of the matter. Exports of hydroxychloroquine and paracetamol will be allowed depending on availability of stock after meeting domestic requirements and existing orders, said the government officials, who asked not to be identified citing rules. Shipments will be restricted and permission will be on humanitarian ground, they added. The spokesman for the trade ministry was not immediately available for comment. Normally used to treat malaria, hydroxychloroqu...
Source: TIME: Health - April 7, 2020 Category: Consumer Health News Authors: Archana Chaudhary / Bloomberg Tags: Uncategorized COVID-19 overnight wire Source Type: news

India will allow some exports of anti-malaria drug after Trump appeal
India will allow some exports of the anti-malaria drug hydroxychloroquine, the foreign ministry said on Tuesday, after U.S. President Donald Trump urged New Delhi to release supplies of the drug seen as a possible treatment for COVID-19. (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

As many as 4,000 patients seriously ill with coronavirus are being treated with hydroxychloroquine
Health officials have sent hydroxychloroquine, typically used to treat malaria and lupus, to 56 hospitals across New York to treat patients suffering serious complications from the virus. (Source: the Mail online | Health)
Source: the Mail online | Health - April 7, 2020 Category: Consumer Health News Source Type: news

Trump ’s aggressive advocacy of malaria drug for treating coronavirus divides medical community
Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine. (Source: The Economic Times)
Source: The Economic Times - April 7, 2020 Category: Consumer Health News Source Type: news

India partially eases export curbs on Hydroxychloroquine, the anti-malaria drug Donald Trump wants
The Indian government had earlier put a hold on exports of hydroxychloroquine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 7, 2020 Category: Pharmaceuticals Source Type: news

Debate heats up over using an anti-malaria drug for COVID-19
Trump trade adviser Navarro promoted hydroxychloroquine in TV interviews. (Source: ABC News: Health)
Source: ABC News: Health - April 6, 2020 Category: Consumer Health News Tags: Health Source Type: news

What to know about malaria drug and coronavirus treatment
Some politicians and doctors are sparring over whether to use an old malaria drug called hydroxychloroquine against the new coronavirus (Source: ABC News: Health)
Source: ABC News: Health - April 6, 2020 Category: Consumer Health News Tags: Health Source Type: news

Trump Again Promotes Use of Unproven Anti-Malaria Drug; Deaths in Country May Be Undercounted
For the second straight day, the president pushed the use of hydroxychloroquine, which has not been proven to treat the coronavirus. Washington State is returning 400 ventilators to be redeployed to states in more dire need. (Source: NYT Health)
Source: NYT Health - April 6, 2020 Category: Consumer Health News Tags: Coronavirus (2019-nCoV) Source Type: news

Kenya: Busia County Pays Sh42 Million to Victims of Toxic Malaria Jab
[Nation] For about five years, parents of 28 children who were injected with a toxic jab at Akichelesit Dispensary in Teso North Constituency, Busia County have cried for justice as their sons and daughters reeled in paralysis. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 6, 2020 Category: Infectious Diseases Source Type: news

Coronavirus Live Updates: Trump Again Promotes Use of Unproven Anti-Malaria Drug; Deaths in Country May Be Undercounted
For the second straight day, the president pushed the use of hydroxychloroquine, which has not been proven to treat the coronavirus. Washington State is returning 400 ventilators to be redeployed to states in more dire need. (Source: NYT Health)
Source: NYT Health - April 6, 2020 Category: Consumer Health News Tags: Coronavirus (2019-nCoV) Source Type: news

Trump Urges Coronavirus Patients to Take Unproven Drug
He said the government was putting millions of doses of the malaria drug hydroxychloroquine into an emergency stockpile even though it has not been approved for Covid-19 treatment. (Source: NYT Health)
Source: NYT Health - April 5, 2020 Category: Consumer Health News Authors: Denise Grady and Andrea Kannapell Tags: Hydroxychloroquine (Drug) Coronavirus (2019-nCoV) Stockpiling Drugs (Pharmaceuticals) Trump, Donald J National Strategic Stockpile Source Type: news

SPECIAL REPORT: Forget Donald Trump's foolish tweets - malaria pills aren't the magic bullet
Chloroquine and hydroxychloroquine were once used to protect travellers from contracting malaria when abroad but their side effects can lead to a sudden, fatal cardiac arrest. (Source: the Mail online | Health)
Source: the Mail online | Health - April 5, 2020 Category: Consumer Health News Source Type: news

Latin America Has Weak Defences Against the Pandemic
This article includes reporting by Ivet González in Havana, Mario Osava in Rio de Janeiro, and Orlando Milesi in Santiago. The post Latin America Has Weak Defences Against the Pandemic appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - April 4, 2020 Category: International Medicine & Public Health Authors: Humberto Marquez Tags: Development & Aid Editors' Choice Featured Headlines Health Human Rights Latin America & the Caribbean Population Regional Categories Coronavirus COVID-19 ECLAC Pan-American Health Organization (PAHO) Poverty World Health Organ Source Type: news

Exclusive: Pressed by Trump, U.S. pushed unproven coronavirus treatment guidance
In mid-March, President Donald Trump personally pressed federal health officials to make malaria drugs available to treat the novel coronavirus, though they had been untested for COVID-19, two sources told Reuters. (Source: Reuters: Health)
Source: Reuters: Health - April 4, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Doctors worldwide say malaria drug is the best coronavirus treatment
Physicians' online platform Sermo asked doctors around the world about range of coronavirus topics. They said US test times lag behind other countries, and most expect a second wave. (Source: the Mail online | Health)
Source: the Mail online | Health - April 4, 2020 Category: Consumer Health News Source Type: news

Malaria drugs aren't the only ones on the shelf that might help coronavirus patients
Treating patients with "moderate" COVID-19 is a way to stop the disease from progressing to a severe stage that would require mechanical ventilation. (Source: L.A. Times - Health)
Source: L.A. Times - Health - April 3, 2020 Category: Consumer Health News Authors: Melissa Healy Source Type: news

Malaria drugs aren't the only ones on the shelf that might help coronavirus patients
Treating patients with "moderate" COVID-19 is a way to stop the disease from progressing to a severe stage that would require mechanical ventilation. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - April 3, 2020 Category: Science Authors: Melissa Healy Source Type: news

Coronavirus: Malaria drug hydroxychloroquine 'most effective'
Of 6,200 physicians surveyed from 30 countries, the majority (37 per cent) said hydroxychloroquine was the 'most effective therapy' for the virus. (Source: the Mail online | Health)
Source: the Mail online | Health - April 3, 2020 Category: Consumer Health News Source Type: news

Nigeria: COVID-19 a New Threat for 1.5 Million Internally Displaced People in Borno State
[MSF] After more than a decade of armed conflict, outbreaks of severe malnutrition, malaria, measles and cholera, approximately 1.5 million internally displaced people (IDPs) in Borno state now face the spectre of COVID-19. Many live in vastly overcrowded camps with poor water and sanitation facilities, limited supplies of hygiene essentials such as soap and water, and often no individual space at all. Functioning health infrastructure in Borno is scarce, and the capacity to refer patients is extremely limited. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 3, 2020 Category: African Health Source Type: news

Marseille’s maverick chloroquine doctor becomes pandemic rock star
French virologist Didier Raoult was one of the first to administer the malaria drug to Covid-19 patients (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 3, 2020 Category: Pharmaceuticals Source Type: news

Exclusive: Sanofi can produce millions of doses of potential coronavirus drug - CEO
Sanofi SA will be able to provide millions of doses of hydroxychloroquine for patients with the illness caused by the novel coronavirus if the old malaria drug proves successful in clinical trials, its chief executive told Reuters on Thursday. (Source: Reuters: Health)
Source: Reuters: Health - April 3, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

World may lack sufficient supply of malaria drugs to treat COVID-19, experts argue
Limited supplies of the anti-malarials chloroquine and hydroxychloroquine could hinder plans to use them to treat COVID-19, experts warned Thursday, adding that the use poses a danger for patients already on the drugs. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 3, 2020 Category: Consumer Health News Source Type: news